- 1Department of TCM, Guangzhou Women and Children’s Medical Center of Guangzhou Medical University, Guangzhou, China
- 2The Second School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
- 3Heilongjiang University of Chinese Medicine, Harbin, China
- 4The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
- 5Department of Emergency, The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China
Background: A traumatic spinal cord injury (TSCI) can lead to severe nerve damage and disability. Cell transplantation therapy has shown great potential in the reconstruction of damaged spinal cords and promoting functional recovery. However, there is a lack of frontiers and futures analysis in the study of cell transplantation in TSCI.
Methods: We used CiteSpace, VOSviewer and biblilometrix R package to perform bibliometric analysis on cell transplantation in TSCI from 2013 to 2023. Bibliometric records were extracted from English articles and reviews from the Web of Science core collection.
Results: The bibliometric analysis included 284 papers published in 154 journals by 1,780 authors from 487 institutions in 41 countries and regions. The number of articles published in the past decade has fluctuated slightly, while the number of article citations has steadily increased. Mainland China and the United States are the leading countries and regions in this field, with the National Natural Science Foundation of China being the most funded foundation, and the United States being the country with the most funded articles. The University of Toronto in Canada is a prolific institution. Michael G. Fehlings has published the most articles, and D Michele Basso is the most cited author. Cell transplantation is the most published journal, and the Journal of Neurotrauma is the most cited journal. Cell and tissue engineering and clinical neurology are the basic disciplines in this field, and cutting-edge disciplines include developmental biology, biochemistry and molecular biology, and materials science and multidisciplinary. This study also helps scholars understand the current hotspots and future trends in this field. Marrow stromal cells, glial progenitor, and cell therapy are current research hotspots in this field, while nerve regeneration, cell therapy, and the safety of transplantation of transplantation may be potential research directions in the future.
Conclusion: Cell transplantation after TSCI is receiving increasing attention. Cell therapy is both the frontier and a possible future trend in TSCI research. In addition, glial progenitor and marrow stromal cells are also current research hotspots. Meanwhile, nerve regeneration and safety of transplantation may be potential research directions. These findings will help further deepen research on cell transplantation for TSCI in scientific work.
1 Introduction
With the increase of global motor vehicles, aging population, and violent crime rate, the incidence of traumatic spinal cord injury (TSCI) has been increasing yearly (Chen et al., 2016; Jiang et al., 2022). TSCI is caused by primary mechanical injury (Ahuja et al., 2017). Unfortunately, secondary spinal cord injury can lead to more serious neurological damage and disability (Tran et al., 2018) and is currently one of the most serious public health problems (Ahuja et al., 2017). Hemodynamics, Methylprednisolone sodium succinate, decompressive surgery, and other methods are often used to treat TSCI, but complications such as neuropathic pain, neuropathic arthropathy, autonomic dysreflexia, genitourinary and gastrointestinal complications still occur (Ahuja et al., 2017). Therefore, it is necessary to explore effective treatment strategies to improve the quality of life of patients with TSCI.
Cell transplantation therapy has shown great potential in rebuilding damaged spinal cord and promoting functional recovery (Oliveri et al., 2014; Assinck et al., 2017). Schwann cells, neural stem cells, progenitor cells, mesenchymal stem cells, olfactory ensheathing cells, and precursor cells of oligodendrocytes are all considered potential cell transplantation options for the treatment of TSCI (Hu et al., 2010; Gómez et al., 2018; Ridler, 2018; Santamaría et al., 2018; Duncan et al., 2020). These cells often promote functional recovery after spinal cord injury by promoting neuronal regeneration, axon regeneration, myelin regeneration, immune regulation, and neuroprotection (Assinck et al., 2017).
Bibliometrics is a quantitative analysis of publications to identify leading countries, institutions, journals, authors, etc. in some fields, and to help researchers understand the current hotspots and future trends in this field (Bornmann and Leydesdorff, 2014; Rousseau, 2014; Ellegaard and Wallin, 2015). With the increasing attention on TSCI and rapid development of cell transplantation research, an increasing number of articles on cell transplantation for TSCI have been published in the past 10 years (Nori et al., 2011; Lu et al., 2012; Kadoya et al., 2016; Assinck et al., 2017; Levi et al., 2018; Cofano et al., 2019). Although there have been some bibliometric studies visualizing representative countries and journals in the field of spinal cord injury, there is a lack of discussion on cell transplantation (Kiraz and Demir, 2020). Additionally, there have been some systematic reviews discussing the research progress of neural stem cell therapy in preclinical and clinical settings of spinal cord injury, qualitatively exploring the contribution of neural stem cells to injury repair and functional recovery (Hosseini et al., 2023). However, quantitative analysis of a large body of literature is lacking (Hosseini et al., 2023). Furthermore, some review articles have analyzed the treatment strategies for spinal cord injury and future research directions, highlighting the need for objective research. But, these analyses remain qualitative rather than quantitative (Venkatesh et al., 2019). Therefor, bibliometric analysis of cell transplantation for TSCI research is still lacking. To fill this gap, we searched for studies on cell transplantation intervention for TSCI from 2013 to 2023, and conducted bibliometric analysis of these articles to sort out the core research forces in this field and clarify the trends and frontiers in this field.
2 Materials and methods
Publications on cell transplantation for TSCI from 2013 to 2023 were obtained from the Science Citation Index-Expanded dataset within the Web of Science Core Collection. Only review articles and original articles related to cell transplantation for TSCI, published in English, from 2013 to 2023, were included. Meanwhile, incomplete, duplicate, and irrelevant studies were excluded. The entire process of data retrieval and selection was independently performed by two authors, with any discrepancies resolved by a third reviewer.
CiteSpace 6.2.R4, Vosviewer 1.6.19 and Bibliometrix 4.1.2 are commonly used tools for bibliometric analysis and visualization. Each software has its advantages (Chen, 2006; van Eck and Waltman, 2017). Vosviewer and Bibliometrix was used to retrieve main information and visualize collaboration networks among countries, institutions, authors, and journals. CiteSpace was used for clustering of thematic categories, as well as visualizing networks, clusters, and bursts of keywords and references. In the generated network graphs, larger nodes indicate higher publication or citation counts, while thicker connections between nodes represent stronger associations. Furthermore, the colors of nodes and links signify different clusters (Liao et al., 2018; Donthu et al., 2021). Graphpad 9.5.1 was utilized to plot publication and citation trends, as well as to categorize thematic clusters (Figure 1).
3 Results
3.1 Main information
The time span of all the included data in this study is from 2013 to 2023. In the retrieved results, there were a total of 284 documents, including 192 articles and 92 reviews. On average, each document has been published for 4.7 years and has an average of 27.55 references cited. These documents were published in 154 different journals and had a total of 1,556 keywords, including 694 author keywords and 862 keywords plus. There were a total of 1,780 co-authors involved in these documents, with 3 authors publishing as sole authors. On average, each document had 7.17 authors, and international co-authorships accounted for 23.24%.
3.1 Publication and citation trends
In terms of the annual distribution of publications, the number of publications steadily increased from 2013 to 2018. However, there was a noticeable decrease in the number of publications from 2019 (n = 30) to 2021 (n = 23). In 2022, the number of publications rapidly rebounded and returned to the levels of 2018 and 2019 (Figure 2). Nevertheless, the citation count of the articles continued to increase annually until 2022, and it remained relatively stable in 2022, similar to the previous year. This suggests that the publication output experienced a slight slowdown from 2019 to 2021 due to certain objective factors, but the quality of articles in the field of cell transplantation for TSCI remains commendable Table 1.
3.2 Analysis of productive authors and highly cited authors
A total of 1,780 authors have published articles in this field. Authors who contribute a large number of articles and authors who are highly cited both reflect their influence in a field. Michael G. Fehlings’s local impact is the highest (Figure 3A). Michael G. Fehlings, Vafa Rahimi-Movaghar and Molly S Shoichet are the top three authors with the highest number of publications (Table 2; Figure 3B). In terms of co-citation, D Michele Basso, Paul Lu, and Michael G. Fehlings are the most highly cited authors (Table 2; Figure 3C). It is evident that Michael G. Fehlings has the highest number of publications, approximately three times more than the second-ranked author, and is also among the top three in terms of co-citations. These findings indicate that Michael G. Fehlings is an important leader in the field of cell transplantation for TSCI.
FIGURE 3. Distribution of Highly Cited Authors, Institutions, Countries, and Journals in the Field of cell transplantation for TSCI. (A) Local impact of authors; (B) Network of authors (n ≥ 2); (C) network of co-cited authors (n ≥ 5); (D) network map of countries (n ≥ 2); (E) network of institutions (n ≥ 2); (F) network of co-cited journals (top30); (G) distribution of disciplinary domains of publications.
3.3 Analysis of countries and regions and funding
A total of 41 countries and regions have been found to contribute to cell transplantation for TSCI. The top three countries with the highest number of publications are PEOPLES R CHINA (n = 84), the United States (n = 82), and Canada (n = 26) (Figure 3D; Table 3). Some collaborations have been formed between different countries and regions, and the thicker lines between countries indicate closer collaborations, such as between China and the United States, German and Brazil, etc. (Figure 3D). In addition, the National Natural Science Foundation of China (n = 46), the National Institutes of Health (n = 28), and the United States Department of Health Human Services (n = 28) are the top three funding sources for publications. Among the top ten funding sources, those from the United States have funded the most articles.
3.4 Analysis of institutions and departments
A total of 487 institutions have published articles on cell transplantation for TSCI. The University of Toronto, with 23 publications, is the institution with the highest output in this field (Table 4). Next are the University Health Network and Krembil Research Institute. The departments with the highest number of publications are Toronto Western Hospital, University of Toronto Temerty Faculty of Medicine, and University of Toronto Department of Surgery (Table 4). It can be seen that Department of Surgery (13 in 23) and Temerty Faculty of Medicine (13 in 23) are the main contributor of the University of Toronto in this field. The collaboration network among institutions shows that the University of Toronto is the leading institution in the field of cell transplantation for TSCI (Figure 3E).
3.5 Analysis of journals with the most publications and highest citation counts
From 2013 to 2023, a total of 154 journals have accepted articles in the field of cell transplantation for TSCI. cell transplantation (n = 12) is the journal with the highest number of publications in this field, followed by Stem Cell Research Therapy (n = 10) and Neural Regeneration Research (n = 9) (Table 5; Figure 3F). In addition, Journal of Neurotrauma (n = 837) is the journal with the highest citation count, followed by Journal of Neuroscience (n = 811) and Experimental Neurology (n = 753).
3.6 Distribution of disciplinary domains of publications
Through CiteSpace’s co-occurrence analysis of disciplinary categories, it was found that there are 8 clusters, primarily including Cell and Tissue Engineering (44.96%), Clinical Neurology (32.65%), and Biomedical (8.40%). These three disciplines have been the most popular from 2013 to 2023 (Figure 3G). In terms of centrality and average age, the most prominent disciplinary classifications are Biochemistry and Molecular Biology (1.0, 2018), Pathology (1.0, 2017), and Materials Science and Multidisciplinary (0.976, 2017). Clearly, the current research on cell transplantation for traumatic spinal cord injuries is an interdisciplinary field that combines Cell and Tissue Engineering and Clinical Neurology, incorporating disciplines such as Biochemistry, Molecular Biology, and Developmental Biology.
3.7 Cluster of highest frequency keywords and top bursting keywords
In addition to spinal cord injury and transplantation, the highest frequency keywords are functional recovery, mesenchymal stem cell, and regeneration (Figure 4A). Traumatic brain injury (0.16), regeneration (0.16), function recovery (0.14), axonal regeneration (0.13) and mesenchymal stem cell (0.11) are keywords with centrality above 0.1, occupying central positions in the keyword network (Figure 4B). A total of 10 clusters were identified through keyword clustering, with bone marrow (n = 56), amyotrophic lateral sclerosis (n = 46), and spinal cord injury (n = 32) being the largest clusters. The average publication year for Cluster #0 bone marrow, Cluster #3 nerve regeneration, and Cluster #4 chimera is 2017, indicating the cutting-edge research in cell transplantation for TSCI (Figure 4C). Bursting keywords reflect the temporal hotspots. Among the top 10 bursting keywords, marrow stromal cells (4.26) exhibit the strongest burst, while the latest topics in safety (2020–2023) suggest future research trends (Figure 4D).
FIGURE 4. Cluster, frequency and burst of keywords and reference. (A) frequency of keywords; (B) centrality of keywords; (C) timeline and clustering of keywords; (D) bursting keywords; (E) clustering of reference; (F) bursting reference.
3.8 Co-citation analysis of references
Co-cited references are the references that are commonly cited together in a group of publications. The references of 284 documents included in this analysis can be divided into 12 clusters. The largest clusters are related to regenerative medicine, glial progenitor, and cell therapy (Figure 4E). The clusters with the most recent average publication years are neuron (2019), cell therapy (2019), and pericytes (2016). Assinck et al., 2017 has the highest number of citations (n = 27) (Assinck et al., 2017), while (Anderson et al., 2017) has the highest centrality score (0.29) (Anderson et al., 2017) (Table 6). The reference with the highest burst intensity is (Hawryluk et al., 2012) (4.58) (Cofano et al., 2019; Cofano et al., 2019; Assinck et al., 2017; Levi et al., 2018) are the most recent bursting references, providing some insights into predicting future research trends (Figure 4F) (Assinck et al., 2017; Levi et al., 2018; Cofano et al., 2019).
4 Discussion
4.1 Analysis of leading countries, funds, institutions, journals, and authors
In this study, we conducted a bibliometric analysis of scientific achievements in the field of cell transplantation for TSCI published from 2013 to 2023 using CiteSpace and VOSviewer. A total of 284 papers were included, authored by 1780 authors from 487 institutions across 41 countries and regions and published in 154 journals. As for the trend of publications and citations from 2013 to 2023, the number of publications showed a steady growth trend with a possible decrease in 2019–2021 due to certain reasons, while the overall citation count kept increasing. It is worth noting that the decline in publication volume during 2019–2021 may be related to the COVID-19 pandemic (Arora et al., 2021; Shamseer et al., 2021). However, the similar local citation count in 2022 compared to 2021 could be due to the fact that only publications up to 24 November 2023 were counted. In addition, considering that publications from 2022 may only be cited by other publications from 2022 to 2023 so far, the average citation count in 2022 may not have actually decreased. These findings indicate that despite some fluctuations, the publications and citation counts in this field have been on the rise in the past decade and their quality is recognized.
Cell transplantation for TSCI is a multidisciplinary research field. After clustering the disciplinary categories of 284 literature using CiteSpace, we found that cell and tissue engineering, clinical neurology, and materials science, multidisciplinary were the top three popular disciplines in the past decade. This further illustrates that the current research focus in this field is primarily rooted in cell and tissue engineering (44.96%) and clinical neurology (32.65%). Though developmental biology (0.963, 2018), biochemistry and molecular biology (1.0, 2018), and materials science and multidisciplinary studies (0.975, 2017) might not have the highest number of projects in the clustering analysis, they still exhibit strong centrality and relatively recent average publication years, indicating their prominence as popular disciplinary categories for current and future research. These findings highlight that the research field of cell transplantation for TSCI is based on the foundation of cell and tissue engineering and clinical neurology, incorporating interdisciplinary realms such as developmental biology, biochemistry and molecular biology, and materials science and multidisciplinary studies.
Cell transplantation, Stem Cell Research Therapy, and Neural Regeneration Research are the most prolific journals in this field and are considered authoritative. Journal of Neurotrauma, Journal of Neuroscience, and Experimental Neurology are the most highly cited journals in this domain.
China, with 84 articles published, the United States, with 82 articles, and Canada, with 26 articles, have made the greatest contributions to this field. Among them, the National Natural Science Foundation of China is the most funded foundation for these articles, while the United States is the country with the most funded articles in this area. Interestingly, the University of Toronto (23/26), University Health Network (18/26), and Krembil Research Institute (15/26) from Canada are the institutions that have published the most articles globally and are the absolute protagonists of Canada in this field. Interestingly, Temerty Faculty of Medicine (13/23), and Department of Surgery (13/23) from the University of Toronto are not only the departments that have published the most articles globally in this field but also the major contributors in Canada, indicating that cooperation between institutions in Canada is the most active.
Michael G. Fehlings is the author who has published the most articles in the field of cell transplantation for TSCI, with 15 documents far exceeding the second-ranked author Vafa Rahimi Movaghar’s 6 documents. Interestingly, he is also one of the top three authors with the most citations. D Michele Basso and Paul Lu have been cited in almost 100 articles, which means that almost one-third of the articles have cited their works (104/284, 94/284). Overall, Michael G. Fehlings, D Michele Basso, Paul Lu are the leading figures in this field.
4.2 Hotspots and trends
In addition to the main keywords “spinal cord injury” and “cell transplant,” the most frequent keywords include “functional recovery,” “mesenchymal stem cell,” and “regeneration.” This indicates that the primary aim of cell transplantation for TSCI is functional recovery and regeneration, and mesenchymal stem cell serve as the main approach for cell transplantation.
The largest keyword cluster in this field is “bone marrow” and “amyotrophic lateral sclerosis,” while “marrow stromal cells” is the most explosive keyword. This suggests that they are still the hot topics of current research in this field. “bone marrow,” “nerve regeneration” and “chimera” represent the latest cluster, and “safety” (2021–2023) is the most recent explosive keyword, indicating a potential trend for ongoing research in the future. It can be observed that marrow stromal cells are an important type of transplanted cells for TSCI, while nerve regeneration and safety represent a future research trend in this field.
Additionally, we note that regeneration medicine, glial progenitor and cell therapy are the largest cluster, and neuron, cell therapy and pericytes are the most recent reference cluster. This indicates that cell therapy will continue to be a significant topic of interest in the field of cell transplantation for TSCI.
(Assinck et al., 2017; Levi et al., 2018; Cofano et al., 2019) are the most recent high-impact reference articles (Assinck et al., 2017; Levi et al., 2018; Cofano et al., 2019). Interestingly, (Cofano et al., 2019), (4.25) is not only the most recent high-impact reference article, but also the one with the highest burst intensity. This article mainly reviews the features, applications, limitations and future prospects of mesenchymal stem cell transplantation for spinal cord injury (Cofano et al., 2019; Assinck et al., 2017), on the other hand, is not only the most recent high-impact reference article, but also the most cited one. It provides a detailed introduction to the cell types commonly used for transplantation to treat spinal cord injury, as well as the mechanisms by which these cell transplants promote functional recovery (Assinck et al., 2017; Levi et al., 2018)’s article mainly discusses the increasing safety of intramedullary transplantation of human neural stem cells for cervical and thoracic spinal cord injury (Levi et al., 2018). Coincidentally, (Anderson et al., 2017), (0.29) is the most central reference article, which suggests that it is feasible to obtain autologous stem cells from peripheral nerves within 5–30 days after acute spinal cord injury and perform highly purified autologous stem cell transplantation within 4–7 weeks after injury. This proves that autologous hematopoietic stem cell transplantation for subacute thoracic spinal cord injury is safe (Anderson et al., 2017). It should be noted that safety is also the most recent explosive keyword. Considering this, we predict that safety of cell transplantation will also be a major focus in future research.
4.3 Advantages and limitations
There are still some inevitable limitations in this study. Firstly, using Web of Science as the only retrieval database may result in some legitimate publications being missed, even though other databases were considered for analysis with a wide range of data available (Zhu and Liu, 2020). Secondly, the credibility of the articles may be affected by the relatively small number of literature included in this study, despite the increasing number of studies on cell transplantation for TSCI (Feng et al., 2021). Lastly, the development trends and topics can be influenced by various biases such as publication bias and citation bias (Urlings et al., 2021), as well as biases based on different algorithms of VOSviewer and CiteSpace software frameworks (Ding and Yang, 2022).
Fortunately, meaningful results in the field of cell transplantation for TSCI have been identified. Firstly, this study provides a framework of research output in the field of TSCI since 2013, which can assist interested scholars in their search for relevant information. In this field, Mainland China and the United States are leading countries and regions, with the National Natural Science Foundation of China being the most frequently funded foundation for the included articles and the United States being the country with the highest number of articles funded by foundations. The University of Toronto in Canada is the institution with the highest number of published articles. Michael G. Fehlings is the author with the highest number of published articles, and Dm Basso is the co-author with the highest number of citations. Cell transplantation is the journal with the highest number of publications, while the Journal of Neurotrauma is the journal with the highest number of citations. Cell and tissue engineering and clinical neurology are the foundational disciplines in this field, integrating frontier disciplines such as developmental biology, biochemistry and molecular biology, and materials science and multidisciplinary. Secondly, this study helps researchers understand the current hotspots and future trends in this field. Marrow stromal cells, glial progenitor, and cell therapy are the current hot topics in this field. Nerve regeneration, cell therapy, and the safety of transplantation may be the future research trends.
5 Conclusion
Cell transplantation after TSCI is receiving increasing attention. Cell therapy is both at the forefront of traumatic spinal cord research and a potential research trend for the future. Additionally, glial progenitor and marrow stromal cells remain hot topics in current research. Furthermore, nerve regeneration and safety of transplantation are potential research directions. These findings contribute to further in-depth research on cell transplantation for TSCI, aiding scientific work in this field.
Data availability statement
This article/Supplementary Material contains the original contributions presented in the study. Further inquiries can be directed to the corresponding authors.
Author contributions
YG: Conceptualization, Data curation, Funding acquisition, Writing–original draft. BG: Data Collection, Formal Analysis, Methodology, Writing–original draft. SS: Formal Analysis, Methodology, Writing–original draft. JL: Methodology, Visualization, Writing–review and editing. XL: Project administration, Resources, Writing–review and editing. HY: Supervision, Validation, Writing–review and editing. ZS: Supervision, Writing–review and editing. SC: Conceptualization, Data curation, Funding acquisition, Writing–original draft.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Guangzhou Basic and Applied Basic Research Project (202102020733, SL 2022A03J01363), Guangzhou Science and Technology Project (20212A011014), PhD Start-up Research Fund (1600064-04), Youth Science and Technology Talent Project (2022RC05).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Reference
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., et al. (2017). Traumatic spinal cord injury. Nat. Rev. Dis. Prim. 3, 17018. doi:10.1038/nrdp.2017.18
Anderson, K. D., Guest, J. D., Dietrich, W. D., Bartlett Bunge, M., Curiel, R., Dididze, M., et al. (2017). Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury. J. Neurotrauma 34 (21), 2950–2963. doi:10.1089/neu.2016.4895
Arora, V. M., Wray, C. M., O’Glasser, A. Y., Shapiro, M., and Jain, S. (2021). Leveling the playing field: accounting for academic productivity during the COVID-19 pandemic. J. Hosp. Med. 16 (2), 120–123. doi:10.12788/jhm.3558
Assinck, P., Duncan, G. J., Hilton, B. J., Plemel, J. R., and Tetzlaff, W. (2017). Cell transplantation therapy for spinal cord injury. Nat. Neurosci. 20 (5), 637–647. doi:10.1038/nn.4541
Bornmann, L., and Leydesdorff, L. (2014). Scientometrics in a changing research landscape: bibliometrics has become an integral part of research quality evaluation and has been changing the practice of research. EMBO Rep. 15 (12), 1228–1232. doi:10.15252/embr.201439608
Chen, C. (2006). CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J. Am. Soc. Inf. Sci. Technol. 57 (3), 359–377. doi:10.1002/asi.20317
Chen, Y., He, Y., and DeVivo, M. J. (2016). Changing demographics and injury profile of new traumatic spinal cord injuries in the United States, 1972–2014. Archives Phys. Med. Rehabilitation 97 (10), 1610–1619. doi:10.1016/j.apmr.2016.03.017
Cofano, F., Boido, M., Monticelli, M., Zenga, F., Ducati, A., Vercelli, A., et al. (2019). Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int. J. Mol. Sci. 20 (11), 2698. doi:10.3390/ijms20112698
Ding, X., and Yang, Z. (2022). Knowledge mapping of platform research: a visual analysis using VOSviewer and CiteSpace. Electron Commer. Res. 22 (3), 787–809. doi:10.1007/s10660-020-09410-7
Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., and Lim, W. M. (2021). How to conduct a bibliometric analysis: an overview and guidelines. J. Bus. Res. 133, 285–296. doi:10.1016/j.jbusres.2021.04.070
Duncan, G. J., Manesh, S. B., Hilton, B. J., Assinck, P., Plemel, J. R., and Tetzlaff, W. (2020). The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury. Glia 68 (2), 227–245. doi:10.1002/glia.23706
Ellegaard, O., and Wallin, J. A. (2015). The bibliometric analysis of scholarly production: how great is the impact? Scientometrics 105 (3), 1809–1831. doi:10.1007/s11192-015-1645-z
Feng, K., Lu, Z., and Zhang, X. (2021). Efficient sample reduction strategy based on adaptive Kriging for estimating failure credibility. Struct. Multidiscip. Optim. 63 (5), 2125–2140. doi:10.1007/s00158-021-02848-9
Gómez, R. M., Sánchez, M. Y., Portela-Lomba, M., Ghotme, K., Barreto, G. E., Sierra, J., et al. (2018). Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs). Glia 66 (7), 1267–1301. doi:10.1002/glia.23282
Hawryluk, G. W., Mothe, A., Wang, J., Wang, S., Tator, C., and Fehlings, M. G. (2012). An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 21 (12), 2222–2238. doi:10.1089/scd.2011.0596
Hosseini, S. M., Borys, B., and Abdolrezaee, S. K. (2023). Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances. Brain 17, awad392. doi:10.1093/brain/awad392
Hu, S. L., Luo, H. S., Li, J. T., Xia, Y. Z., Li, L., Zhang, L. J., et al. (2010). Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit. Care Med. 38 (11), 2181–2189. doi:10.1097/CCM.0b013e3181f17c0e
Jiang, B., Sun, D., Sun, H., Ru, X., Liu, H., Ge, S., et al. (2022). Prevalence, incidence, and external causes of traumatic spinal cord injury in China: a nationally representative cross-sectional survey. Front. Neurology 12, 784647. doi:10.3389/fneur.2021.784647
Kadoya, K., Lu, P., Nguyen, K., Lee-Kubli, C., Kumamaru, H., Yao, L., et al. (2016). Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nat. Med. 22 (5), 479–487. doi:10.1038/nm.4066
Kiraz, M., and Demir, E. (2020). A bibliometric analysis of publications on spinal cord injury during 1980-2018. World Neurosurg. 136, e504–e513. doi:10.1016/j.wneu.2020.01.064
Levi, A. D., Okonkwo, D. O., Park, P., Jenkins, A. L., Kurpad, S. N., Parr, A. M., et al. (2018). Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury. Neurosurgery 82 (4), 562–575. doi:10.1093/neuros/nyx250
Liao, H., Tang, M., Luo, L., Li, C., Chiclana, F., and Zeng, X. J. (2018). A bibliometric analysis and visualization of medical big data research. Sustainability 10 (1), 166. doi:10.3390/su10010166
Lu, P., Wang, Y., Graham, L., McHale, K., Gao, M., Wu, D., et al. (2012). Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150 (6), 1264–1273. doi:10.1016/j.cell.2012.08.020
Nori, S., Okada, Y., Yasuda, A., Tsuji, O., Takahashi, Y., Kobayashi, Y., et al. (2011). Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc. Natl. Acad. Sci. 108 (40), 16825–16830. doi:10.1073/pnas.1108077108
Oliveri, R. S., Bello, S., and Biering-Sørensen, F. (2014). Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models. Neurobiol. Dis. 62, 338–353. doi:10.1016/j.nbd.2013.10.014
Ridler, C. (2018). Spinal cord injury: human neural stem cells elicit regeneration after spinal cord injury in monkeys. Nat. Rev. Neurol. 14 (5), 252. doi:10.1038/nrneurol.2018.32
Rousseau, R. (2014). Library science: forgotten founder of bibliometrics. Nature 510 (7504), 218. doi:10.1038/510218e
Santamaría, A. J., Solano, J. P., Benavides, F. D., and Guest, J. D. (2018). Intraspinal delivery of schwann cells for spinal cord injury. Methods Mol. Biol. 1739, 467–484. doi:10.1007/978-1-4939-7649-2_31
Shamseer, L., Bourgeault, I., Grunfeld, E., Moore, A., Peer, N., Straus, S. E., et al. (2021). Will COVID-19 result in a giant step backwards for women in academic science. J. Clin. Epidemiol. 134, 160–166. doi:10.1016/j.jclinepi.2021.03.004
Tran, A. P., Warren, P. M., and Silver, J. (2018). The biology of regeneration failure and success after spinal cord injury. Physiol. Rev. 98 (2), 881–917. doi:10.1152/physrev.00017.2017
Urlings, M. J. E., Duyx, B., Swaen, G. M. H., Bouter, L. M., and Zeegers, M. P. (2021). Citation bias and other determinants of citation in biomedical research: findings from six citation networks. J. Clin. Epidemiol. 132, 71–78. doi:10.1016/j.jclinepi.2020.11.019
van Eck, N. J., and Waltman, L. (2017). Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics 111 (2), 1053–1070. doi:10.1007/s11192-017-2300-7
Venkatesh, K., Ghosh, S. K., Mullick, M., Manivasagam, G., and Sen, D. (2019). Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications. Cell Tissue Res. 377 (2), 125–151. doi:10.1007/s00441-019-03039-1
Keywords: cell transplantation, traumatic spinal cord injury, bibliometric analysis, marrow stromal cells, cell therapy, safety
Citation: Guo Y, Gao B, Sun S, Li J, Lv X, Yin H, Sun Z and Cai S (2023) Research hotspots and trend analysis of cell transplantation in traumatic spinal cord injury: a bibliometric and visualized analysis. Front. Pharmacol. 14:1326583. doi: 10.3389/fphar.2023.1326583
Received: 23 October 2023; Accepted: 29 November 2023;
Published: 11 December 2023.
Edited by:
Santhosh Kumar Pasupuleti, Indiana University School of Medicine, United StatesReviewed by:
Andy Wai Kan Yeung, University of Hong Kong, ChinaVenkatesh Katari, University of Toledo, United States
Chiranjeevi Tikka, Indiana University School of Medicine, United States
Copyright © 2023 Guo, Gao, Sun, Li, Lv, Yin, Sun and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongna Yin, MTMxMDE1ODE1ODhAMTYzLmNvbQ==; Zhongren Sun, c3pyMDA2QDE2My5jb20=; Shuo Cai, MTQ1NDc5OTEwOEBxcS5jb20=
†These authors have contributed equally to this work and share first authorship